Skip to main content
TipRanks
Go Ultimate75% OFF

MDB Capital Holdings, LLC Class A (MDBH) AI Stock Analysis

15 Followers
MDBH

MDB Capital Holdings, LLC Class A

(NASDAQ:MDBH)

Select Model
Rating:44Neutral
Price Target:$1.50▼(-0.20% Downside)
Action:reiterated
Date:11/14/26

The overall score of 44 reflects a high-risk, early-stage company with a glimmer of strategic potential. The primary drags are the severely negative financial performance and cash flow, which indicate a fundamental lack of sustainability. This is compounded by a bearish technical trend and a lack of traditional valuation support. The most significant positive factor is the earnings call, where management's detailed plan for non-dilutive monetization of assets and strict cost discipline provides a potential, though highly uncertain, path to value creation.

Positive Factors
Low leverage and balance-sheet cushionMinimal debt reduces fixed financial obligations and gives MDB greater flexibility to manage uneven capital-markets activity. The sizable equity base provides a cushion while management pursues asset monetization, partnerships, and potential growth without relying immediately on additional borrowing.
Negative Factors
Persistent losses and deeply negative net marginRecurring losses show that current revenue does not adequately support MDB’s operating structure, even with a positive gross margin. Unless transaction income scales or expenses fall further, continued losses can erode equity and limit the company’s ability to reinvest in growth.

MDB Capital Holdings, LLC Class A (MDBH) vs. SPDR S&P 500 ETF (SPY)

-80%-60%-40%-20%0%20%MDBH-55.92%SPY+14.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$15.70M
Dividend Yield
―
Average Volume (3M)
3,586
Price to Earnings (P/E)
-0.5
Beta (1Y)
0.72
Revenue Growth
91.75%
EPS Growth
-385.99%
Country
US
Employees
14
Sector
Financial
Sector Strength
68
Industry
Financial - Capital Markets

MDB Capital Holdings, LLC Class A Business Overview & Revenue Model

Company Description

MDB Capital Holdings, LLC functions primarily as a broker-dealer through its subsidiary operations. The company's activities are divided into two main areas: Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer...

MDB Capital Holdings, LLC Class A Earnings Call Summary

Earnings Call Date:Aug 13, 2026(Q2-2026)|% Change Since:-50.23%|Next Earnings Date:May 21, 2025
Earnings Call SentimentPositive

The call presents a cautiously optimistic outlook: management acknowledges clear and material market headwinds (valuation pressure, fewer launches, modest H1 transactions and a smaller-than-expected eXoZymes financing) but highlights several concrete near-term catalysts (Paulex IPO and 2027 data readouts, PatentVest spin-out, Public Ventures partnership discussions, and eXoZymes manufacturing/commercialization advances). The tone emphasizes operational discipline (targeting $5–6M annual OpEx), non-dilutive monetization strategies, and multiple value-inflection events that could materially re-rate MDB if executed. Given the balance of tangible near-term catalysts and actions to reduce dilution against the ongoing market challenges and execution risks, the call leans positive but remains cautious.

Positive Updates

Clear near-term catalysts (Paulex IPO & data readouts)
Paulex Bio is nearing filing its registration statement for an IPO (targeted in Q4 2026) with clinical data readouts expected in early 2027; MDB holds ~7.1 million Paulex shares — management describes the drug as potentially 'earth-shattering' for diabetes and highly synergistic with GLP-1 therapies.

Negative Updates

Sustained microcap market headwinds and valuation pressure
MDB stock is down from IPO levels; management repeatedly acknowledged the sub-$200M microcap sector is neglected, institutional fund flows have concentrated in the largest names, and public-company count declined materially (from ~8,000 to <4,000), reducing investor demand for small IPOs.

Company Guidance

Guidance from the call was to prioritize monetizing four core assets and running a very lean public company rather than raising new capital: target run-rate operating expenses of $5–6 million per year (about $6M after planned spinouts/partnerships), offset by fee income and aiming to avoid dilution; spin out/financing for PatentVest and pursue a partner or sale for Public Ventures (discussions/LOIs with ~4–5 parties, target to wrap in the next quarter); expect Paulex to file an IPO registration and target an IPO in Q4 with key clinical readouts in early 2027; eXoZymes is closing manufacturing and commercial partnerships (OpEx ~ $10M/year) and MDB holds ~4.1M shares (+ warrants) of eXoZymes and ~7.1M shares (+ warrants) of Paulex while owning 100% of Public Ventures and PatentVest; MDB noted two transactions in H1 (including Ticketplus) with a pipeline that could produce ~2 transactions in H2 and at least one potentially significant fee transaction, and reminded investors there are roughly 1,000 sub-$200M public companies (about 2% of market cap) amid a market where ~70% of funding has flowed to AI and the Russell Microcap’s average market cap exceeds $2.5B.

MDB Capital Holdings, LLC Class A Financial Statement Overview

Summary

Financial performance is critically weak. While TTM revenue growth to $6.5M is a positive signal, it is overshadowed by a deep TTM net loss of $34.2M and a severe operating cash burn of $8.0M. The company is fundamentally unprofitable and cannot self-fund its operations, making it a high-risk, early-stage entity.

Income Statement

18Very Negative

Balance Sheet

72Positive

Cash Flow

15Very Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Dec 2022Dec 2021
Income Statement
Total Revenue7.01M4.28M2.22M4.23M1.12M0
Gross Profit3.16M-10.69M-17.84M-4.39M-1.71M-1.97M
EBITDA-32.87M-16.95M12.33M-9.76M-5.97M-5.67M
Net Income-34.25M-21.25M11.69M-6.97M-5.31M-15.10M
Balance Sheet
Total Assets37.49M63.74M71.98M42.99M25.70M8.25M
Cash, Cash Equivalents and Short-Term Investments10.62M13.22M20.44M6.11M4.95M6.23M
Total Debt524.00K609.00K711.50K2.42M1.42M720.63K
Total Liabilities1.43M3.16M1.90M5.67M2.59M1.49M
Stockholders Equity36.18M60.69M70.16M37.31M22.64M6.24M
Cash Flow
Free Cash Flow-8.18M-5.73M-8.49M-7.60M-6.77M-6.26M
Operating Cash Flow-8.05M-5.68M-9.04M-7.16M-6.57M-5.83M
Investing Cash Flow863.10K-49.00K22.89M-8.20M-16.38M-423.39K
Financing Cash Flow0069.30K17.76M21.68M0

MDB Capital Holdings, LLC Class A Technical Analysis

Technical Analysis SentimentNegative
Last Price1.50

Price Trends

50DMA2.11Negative
100DMA2.62Negative
200DMA2.94Negative

Market Momentum

MACD-0.14Negative
RSI42.39Neutral
STOCH76.92Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MDBH, the sentiment is Negative. The current price of 1.50 is below the 20-day moving average (MA) of 1.65, below the 50-day MA of 2.11, and below the 200-day MA of 2.94, indicating a bearish trend. The MACD of -0.14 indicates Negative momentum. The RSI at 42.39 is Neutral, neither overbought nor oversold. The STOCH value of 76.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MDBH.

MDB Capital Holdings, LLC Class A Risk Analysis

MDB Capital Holdings, LLC Class A disclosed 70 risk factors in its most recent earnings report. MDB Capital Holdings, LLC Class A reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.Changes to United States tariff and import/export regulations and the conflict in the Persian Gulf may have an adverse effect on our business, financial condition and results of operations.Q2, 2026
2.Government Action on tariffs and research grants and other funding may impede our ability to conduct our research and to raise capital by and for our partner companies and other clients.Q2, 2026
3.Changes to United States tariff and import/export regulations and the conflict in the Persian Gulf may have an adverse effect on our business, financial condition and results of operations.Q1, 2026

MDB Capital Holdings, LLC Class A Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

MDBH against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
COHNCOHN64Neutral$32.79M1.0233.48%37.99%-43.28%290.47%
MDBHMDBH44Neutral$15.70M-0.46-67.54%―91.75%-385.99%
DOMHDOMH43Neutral$18.65M-0.07-536.69%―-11.35%-283.65%
SIEBSIEB39Underperform$71.78M-20.14-3.88%―13.48%-146.43%

* Financial Sector Average

Performance Comparison

0%100%200%MDBHCOHNSIEBDOMHTOPGSIWDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
MDBH and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MDBHMDB Capital Holdings, LLC Class A1.50-2.13-58.60%
COHNCohen & Company9.74-3.45-26.16%
SIEBSiebert Financial1.70-1.07-38.63%
DOMHDominari Holdings Inc.0.78-3.10-79.90%
TOPZhong Yang Financial Group Ltd.17.0011.70220.82%
GSIWGarden Stage Ltd.10.41-18.45-63.93%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 14, 2026